Discover open access scientific publications

Search, annotate, share and cite publications

Publications by H. Tilly

A FDG-PET Driven Consolidation Strategy in Diffuse Large B-Cell Lymphoma: Final Results of a Randomized Phase II Study

Blood

English

Single Nucleotide Polymorphisms in ABCB1 and CBR1 Can Predict Toxicity to R-Chop Type Regimens in Patients With Diffuse Non-Hodgkin Lymphoma

Haematologica

Hematology

2015

English

The Proportion of Activated B-Cell Like Subtype Among De Novo Diffuse Large B-Cell Lymphoma Increases With Age

Haematologica

Hematology

2011

English

LOW NK CELL COUNT AT DIAGNOSIS IS ASSOCIATED WITH SHORTER PFS IN ELDERLY PATIENTS WITH DLBCL TREATED WITH RCHOP AND RANDOMIZED FOR LENALIDOMIDE MAINTENANCE: A LYSA STUDY

Hematological Oncology

English

Targeted Genotyping of Circulating Tumor Dna for Classical Hodgkin Lymphoma Monitoring: A Prospective Study

Hematological Oncology

English

Comparison of Clinical Scoring Systems in Aggressive B-Cell Lymphomas (Bcl): An Individual Patient-Level Analysis Across International Trial

Hematological Oncology

English

Bone Marrow Involvement, but No Blood Involvement, Impairs Survival in Angioimmunoblastic T Cell Lymphoma: An Ancillary Study of the Revail Trial

Hematological Oncology

English

Response to A+chp by Cd30 Expression in the Echelon-2 Trial

Hematological Oncology

English

Safety and Efficacy of Atezolizumab, Obinutuzumab and Venetoclax Combination for Relapsed/Refractory Non-Hodgkin Lymphomas: Results From the Safety-Run of a Lysa Study

Hematological Oncology

English

Interim Update From a Phase 2 Multicenter Study of Tazemetostat, an Ezh2 Inhibitor, in Patients With Relapsed or Refractory Follicular Lymphoma

Hematological Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by H. Tilly

A FDG-PET Driven Consolidation Strategy in Diffuse Large B-Cell Lymphoma: Final Results of a Randomized Phase II Study

Single Nucleotide Polymorphisms in ABCB1 and CBR1 Can Predict Toxicity to R-Chop Type Regimens in Patients With Diffuse Non-Hodgkin Lymphoma

The Proportion of Activated B-Cell Like Subtype Among De Novo Diffuse Large B-Cell Lymphoma Increases With Age

LOW NK CELL COUNT AT DIAGNOSIS IS ASSOCIATED WITH SHORTER PFS IN ELDERLY PATIENTS WITH DLBCL TREATED WITH RCHOP AND RANDOMIZED FOR LENALIDOMIDE MAINTENANCE: A LYSA STUDY

Targeted Genotyping of Circulating Tumor Dna for Classical Hodgkin Lymphoma Monitoring: A Prospective Study

Comparison of Clinical Scoring Systems in Aggressive B-Cell Lymphomas (Bcl): An Individual Patient-Level Analysis Across International Trial

Bone Marrow Involvement, but No Blood Involvement, Impairs Survival in Angioimmunoblastic T Cell Lymphoma: An Ancillary Study of the Revail Trial

Response to A+chp by Cd30 Expression in the Echelon-2 Trial

Safety and Efficacy of Atezolizumab, Obinutuzumab and Venetoclax Combination for Relapsed/Refractory Non-Hodgkin Lymphomas: Results From the Safety-Run of a Lysa Study

Interim Update From a Phase 2 Multicenter Study of Tazemetostat, an Ezh2 Inhibitor, in Patients With Relapsed or Refractory Follicular Lymphoma